FDA Inspection 1238381 — HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.
The FDA completed an inspection of HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD. on Apr 5, 2024 in Shijiazhuang. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 5, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shijiazhuang (China)